Chronic kidney disease and HIV in the era of antiretroviral treatment: findings from a 10-year cohort study in a west African setting

[1]  B. Gazzard,et al.  Chronic Kidney Disease Risk in African and Caribbean Populations With HIV , 2018, The Journal of infectious diseases.

[2]  A. Bello,et al.  Chronic kidney disease in the global adult HIV-infected population: A systematic review and meta-analysis , 2018, PloS one.

[3]  A. Bello,et al.  Prevalence and correlates of chronic kidney disease (CKD) among ART-naive HIV patients in the Niger-Delta region of Nigeria , 2018, Medicine.

[4]  Aimee J Guerrero,et al.  Renal effects of non-tenofovir antiretroviral therapy in patients living with HIV , 2018, Drugs in context.

[5]  E. Agaba,et al.  Prevalence of chronic kidney disease among antiretroviral naïve human immunodeficiency virus-infected patients , 2018 .

[6]  J. Ananworanich,et al.  Chronic kidney disease incidence and survival of Thai HIV-infected patients , 2017, AIDS.

[7]  A. Ahmadi,et al.  Effect of mindfulness-based cognitive therapy on quality of life and self-efficacy in dialysis patients , 2017, Journal of Renal Injury Prevention.

[8]  M. Peeters,et al.  Boosted protease inhibitor monotherapy versus boosted protease inhibitor plus lamivudine dual therapy as second-line maintenance treatment for HIV-1-infected patients in sub-Saharan Africa (ANRS12 286/MOBIDIP): a multicentre, randomised, parallel, open-label, superiority trial. , 2017, The lancet. HIV.

[9]  E. Igumbor,et al.  Changes in estimated glomerular filtration rate over time in South African HIV-1-infected patients receiving tenofovir: a retrospective cohort study , 2017, Journal of the International AIDS Society.

[10]  E. Delaporte,et al.  Evolution of Renal Function in African Patients Initiating Second-Line Antiretroviral Treatment: Findings from the ANRS 12169 2LADY Trial , 2016, Antiviral therapy.

[11]  J. Nachega,et al.  Incidence of stage 3 chronic kidney disease and progression on tenofovir-based regimens , 2016, AIDS.

[12]  Dada Samuel Ayokunle,et al.  Prevalence of chronic kidney disease in newly diagnosed patients with Human immunodeficiency virus in Ilorin, Nigeria. , 2015, Jornal brasileiro de nefrologia : 'orgao oficial de Sociedades Brasileira e Latino-Americana de Nefrologia.

[13]  Tewogbade Adeoye Adedeji,et al.  Prevalence and Pattern of Chronic Kidney Disease in Antiretroviral-Naïve Patients with HIV/AIDS , 2015, Journal of the International Association of Providers of AIDS Care.

[14]  A. Mocroft,et al.  Development and Validation of a Risk Score for Chronic Kidney Disease in HIV Infection Using Prospective Cohort Data from the D:A:D Study , 2015, PLoS medicine.

[15]  A. Mocroft,et al.  Development and Validation of a Risk Score for Chronic Kidney Disease in HIV Infection Using Prospective Cohort Data from the D:A:D Study , 2015, PLoS medicine.

[16]  J. Kopp,et al.  HIV and chronic kidney disease , 2015, Clinical nephrology.

[17]  H. Stellbrink,et al.  Protease Inhibitors and Renal Function in Patients with HIV Infection: a Systematic Review , 2015, Infectious Diseases and Therapy.

[18]  H. Yazaki,et al.  Long-term exposure to tenofovir continuously decrease renal function in HIV-1-infected patients with low body weight: results from 10 years of follow-up , 2014, AIDS.

[19]  F. Salem,et al.  The changing epidemiology of HIV-related chronic kidney disease in the era of antiretroviral therapy. , 2014, Kidney international.

[20]  B. Chi,et al.  Effect of baseline renal function on tenofovir-containing antiretroviral therapy outcomes in Zambia. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[21]  F. Sarfo,et al.  High prevalence of renal dysfunction and association with risk of death amongst HIV-infected Ghanaians. , 2013, The Journal of infection.

[22]  A. Onayade,et al.  A community study of the prevalence, risk factors and pattern of chronic kidney disease in Osun State, South West Nigeria. , 2013, West African journal of medicine.

[23]  H. Trottier,et al.  Association between tenofovir exposure and reduced kidney function in a cohort of HIV-positive patients: results from 10 years of follow-up. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[24]  Peter Reiss,et al.  Association between antiretroviral exposure and renal impairment among HIV-positive persons with normal baseline renal function: the D:A:D study. , 2013, The Journal of infectious diseases.

[25]  K. H. Hullsiek,et al.  Determinants of incident chronic kidney disease and progression in a cohort of HIV‐infected persons with unrestricted access to health care , 2013, HIV medicine.

[26]  Chapter 1: Definition and classification of CKD , 2012, Kidney International Supplements.

[27]  C. Swanepoel,et al.  The spectrum of renal histologies seen in HIV with outcomes, prognostic indicators and clinical correlations. , 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[28]  C. Sabin,et al.  Baseline Kidney Function as Predictor of Mortality and Kidney Disease Progression in HIV-Positive Patients , 2012 .

[29]  Richard D Moore,et al.  Risk factors for chronic kidney disease in a large cohort of HIV-1 infected individuals initiating antiretroviral therapy in routine care , 2012, AIDS.

[30]  M. Shlipak,et al.  Association of tenofovir exposure with kidney disease risk in HIV infection , 2012, AIDS.

[31]  Jianyun Wu,et al.  Relative risk of renal disease among people living with HIV: a systematic review and meta-analysis , 2012, BMC Public Health.

[32]  J. He,et al.  The New Epidemiology of HIV-Related Kidney Disease , 2012, Journal of AIDS & clinical research.

[33]  H. Izzedine,et al.  Prevalence of chronic kidney disease among people living with HIV/AIDS in Burundi: a cross-sectional study , 2011, BMC nephrology.

[34]  C. Katlama,et al.  Risk factors of chronic kidney disease in HIV-infected patients. , 2011, Clinical journal of the American Society of Nephrology : CJASN.

[35]  James E. Novak,et al.  Prevalence of Kidney Disease in HIV-Infected and Uninfected Rwandan Women , 2011, PloS one.

[36]  L. Szczech,et al.  Cystatin C, albuminuria, and 5-year all-cause mortality in HIV-infected persons. , 2010, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[37]  Mardge H. Cohen,et al.  The Impact of Kidney Function at Highly Active Antiretroviral Therapy Initiation on Mortality in HIV-Infected Women , 2010, Journal of acquired immune deficiency syndromes.

[38]  M. Tonelli,et al.  Systematic review and meta-analysis: renal safety of tenofovir disoproxil fumarate in HIV-infected patients. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[39]  A. Mocroft,et al.  Estimated glomerular filtration rate, chronic kidney disease and antiretroviral drug use in HIV-positive patients , 2010, AIDS.

[40]  S. Anderson,et al.  The aging kidney: physiological changes. , 2010, Advances in chronic kidney disease.

[41]  F. Cappuccio,et al.  Assessment of GFR by four methods in adults in Ashanti, Ghana: the need for an eGFR equation for lean African populations , 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[42]  Jeffrey N. Martin,et al.  HIV-infected persons continue to lose kidney function despite successful antiretroviral therapy , 2009, AIDS.

[43]  C. Gilks,et al.  Estimating Glomerular Filtration Rate in HIV-Infected Adults in Africa: Comparison of Cockcroft–Gault and Modification of Diet in Renal Disease Formulae , 2008, Antiviral therapy.

[44]  I. Williams,et al.  Severe renal dysfunction and risk factors associated with renal impairment in HIV-infected adults in Africa initiating antiretroviral therapy. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[45]  Tom Greene,et al.  Expressing the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serum creatinine values. , 2007, Clinical chemistry.

[46]  Sophia Rabe-Hesketh,et al.  Multilevel and Longitudinal Modeling Using Stata , 2005 .

[47]  L. Szczech,et al.  Development of Proteinuria or Elevated Serum Creatinine and Mortality in HIV-Infected Women , 2003, Journal of acquired immune deficiency syndromes.

[48]  Ethan M Balk,et al.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[49]  T. Mountokalakis.  The renal consequences of arterial hypertension. , 1997, Kidney international.

[50]  K. H. Yao,et al.  Prevalence and risk factors for chronic kidney disease in general population of Yopougon ( Côte d ’ ivoire ) ; a cross-sectional study , 2018 .

[51]  A. Mocroft,et al.  Cumulative and current exposure to potentially nephrotoxic antiretrovirals and development of chronic kidney disease in HIV-positive individuals with a normal baseline estimated glomerular filtration rate: a prospective international cohort study. , 2016, The lancet. HIV.

[52]  G. Eknoyan,et al.  Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[53]  Kdoqi Disclaimer.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[54]  D. James,et al.  Definition and classification , 1994 .